and us dt trial in august 2010 (enrollment completed may 2012). fda approval for btt in 2012 and dt in 2017. withdrawn from market in june 2021 mvad heartware heartware's mvad pump is a development-stage miniature ventricular assist device, approximately one-third the size of heartware's hvad pump. heartware completed glp studies (september 2011). duraheart terumo magnetically levitated centrifugal pump. ce approved, us fda trials underway as at january 2010. thoratec pvad (paracorporeal ventricular assist device) thoratec pulsatile system includes three major components: blood pump, cannulae and pneumatic driver (dual drive console or portable vad driver). ce mark authorized. received fda approval for btt in 1995 and for post-cardiotomy recovery (open heart surgery) in 1998. ivad—implantable ventricular assist device thoratec pulsatile system includes three major components: blood pump, cannulae and pneumatic driver (dual drive console or portable vad driver). ce mark authorized. received fda approval for btt in 2004. authorized only for internal implant, not for paracorporeal implant due to reliability issues. fivad leviticus cardio versatile wireless system for lvad. allow 6-hour of freedom to the patients investigation device, 2 patients trial conduct on dec 2018 with jarvik 2000 lvad in astana by prof pya.